Search research articles

ACERCA DE JoVE

Visión General Liderazgo Blog Centro de Ayuda JoVE

AUTORES

Proceso de Publicación Consejo Editorial Alcance y Políticas Revisión por Pares Preguntas Frecuentes Enviar

BIBLIOTECARIOS

Testimonios Suscripciones Acceso Recursos Consejo Asesor de Bibliotecas Preguntas Frecuentes

INVESTIGACIÓN

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archivo

EDUCACIÓN

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Centro de Recursos para Profesores Sitio de Profesores

Términos y Condiciones de Uso

Política de Privacidad

Videos de Conceptos Relacionados

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Metastasis

Metastasis

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Tumor Progression

Tumor Progression

Cancers Originate from Somatic Mutations in a Single Cell

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por

Same author

Reply to: "On the Distinction Between Prognostic and Predictive Inference in Multicancer Early Detection" and "Interpretation of Survival Outcomes in Multicancer Early Detection Testing Requires Caution".

JCO precision oncology·2026

Same author

Assessment of human immunity to A/H3N2 influenza subclade K during 2025 emergence.

EBioMedicine·2026

Same author

Plasma signals of lung tumor promotion for molecular cancer prevention.

Cell·2026

Same author

Immunotherapy drug target identification using machine learning and patient-derived tumour explant validation.

Nature machine intelligence·2026

Same author

Nociceptive innervation limits tertiary lymphoid structures to promote lung cancer.

Cell·2026

Same author

Subclonal immune evasion in non-small cell lung cancer.

Cancer cell·2026

Same journal

A native sulfur deposit in Gale crater, Mars.

Science (New York, N.Y.)·2026

Same journal

Coordinated demise of harmful algal blooms.

Science (New York, N.Y.)·2026

Same journal

Genetic effects put into context.

Science (New York, N.Y.)·2026

Same journal

Bacteria share proteins to survive antibiotics.

Science (New York, N.Y.)·2026

Same journal

Impacts shaped Earth's first continents.

Science (New York, N.Y.)·2026

Same journal

Erratum for the Report "Covalently bonded single-molecule junctions with stable and reversible photoswitched conductivity" by C. Jia <i>et al</i>.

Science (New York, N.Y.)·2026

Ver todos los artículos relacionados

Search research articles

Video Experimental Relacionado

Updated: Mar 22, 2026

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread

Published on: July 7, 2023

La metástasis como un proceso evolutivo

Samra Turajlic¹, Charles Swanton²

¹The Francis Crick Institute, 44 Lincoln's Inn Fields, London WC2A 3LY2, UK. Renal and Skin Units, The Royal Marsden Hospital, London SW3 6JJ, UK.

Science (New York, N.Y.)

|April 29, 2016

Resumen

Este resumen es generado por máquina.

El cáncer metastásico sigue siendo en gran medida incurable, pero la comprensión de su evolución genética puede revelar nuevas vulnerabilidades terapéuticas. Los estudios comparativos sugieren que los principales cambios genéticos, como la inestabilidad cromosómica, impulsan el desarrollo de la enfermedad metastásica.

Más Videos Relacionados

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior

Published on: June 13, 2016

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Videos de Experimentos Relacionados

Last Updated: Mar 22, 2026

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread

Published on: July 7, 2023

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior

Published on: June 13, 2016

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Área de la Ciencia:

En el campo de la oncología
Biología del cáncer
Biología evolutiva

Sus antecedentes:

La enfermedad metastásica es una de las principales causas de mortalidad por cáncer, con tratamientos eficaces limitados.
Los subclones metastásicos pueden surgir durante la progresión del tumor, lo que complica las estrategias de tratamiento.

Objetivo del estudio:

Revisar estudios comparativos de tumores primarios y metastásicos.
Para entender la evolución genética de la enfermedad metastásica.
Identificar las posibles vulnerabilidades terapéuticas en los cánceres metastásicos.

Principales métodos:

Análisis genómico comparativo de tumores primarios y metastásicos.
Revisión de la literatura científica reciente sobre la evolución y la metástasis del cáncer.

Principales resultados:

La evolución de la enfermedad metastásica implica cambios genéticos distintos en comparación con los tumores primarios.
Los cambios macroevolutivos, incluida la inestabilidad cromosómica, están implicados en la metástasis.
Comprender los patrones temporales y las rutas de la colonización metastásica es crucial.

Conclusiones:

Los estudios comparativos ofrecen información sobre la biología de las metástasis.
La identificación de diferencias entre tumores primarios y metastásicos puede guiar el desarrollo terapéutico.
Superar los desafíos en el estudio de la evolución metastásica es clave para mejorar los resultados de los pacientes.